Submission for OMB Review; Comment Request; “Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures”
| Citation | 84 FR 35376 |
| Record Number | 2019-15562 |
| Published date | 23 July 2019 |
| Section | Notices |
| Court | United States Patent And Trademark Office |
Federal Register, Volume 84 Issue 141 (Tuesday, July 23, 2019)
[Federal Register Volume 84, Number 141 (Tuesday, July 23, 2019)]
[Notices]
[Page 35376]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15562]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
United States Patent and Trademark Office
Submission for OMB Review; Comment Request; ``Requirements for
Patent Applications Containing Nucleotide Sequence and/or Amino Acid
Sequence Disclosures''
The United States Patent and Trademark Office (USPTO) will submit
to the Office of Management and Budget (OMB) for clearance the
following proposal for collection of information under the provisions
of the Paperwork Reduction Act.
Agency: United States Patent and Trademark Office, Commerce.
Title: Requirements for Patent Applications Containing Nucleotide
Sequence and/or Amino Acid Sequence Disclosures.
OMB Control Number: 0651-0024.
Form Number(s):
PTO/SB/93.
Type of Request: Regular.
Number of Respondents: 28,850.
Estimated Time per Response: The USPTO estimates that it will take
approximately 6 minutes (0.10 hours) to 6 hours to complete a single
item in this collection. This includes the time to gather the necessary
information, create the documents, and submit the completed request to
the USPTO.
Burden Hours: 163,955 hours.
Cost Burden: $1,573,140.00.
Needs and Uses: Patent applications that contain nucleotide and/or
amino acid sequence disclosures that fall within the definitions of 37
CFR 1.821(a) must include, as a separate part of the application
disclosure, a copy of the sequence listing in accordance with the
requirements in 37 CFR 1.821-1.825. Applicants may submit sequence
listings for both U.S. and international patent applications. The USPTO
uses the sequence listings during the examination process to determine
the patentability of the associated patent application. The USPTO also
uses the sequence listings to support publication of patent
applications and issued patents. Sequence listings are searchable after
publication.
Frequency: On occasion.
Respondent's Obligation: Required to Obtain or Retain Benefits.
OMB Desk Officer: Nicholas A. Fraser, email:
[email protected].
Once submitted, the request will be publicly available in
electronic format through reginfo.gov. Follow the instructions on the
website to view Department of Commerce collections currently under
review by OMB.
Further information can be obtained by:
Email: [email protected]. Include ``0651-
0024 information request'' in the subject line of the message.
Mail: Marcie Lovett, Chief, Records and Information
Governance Branch, Office of the Chief Administrative Officer, United
States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA
22313-1450.
Written comments and recommendations for the proposed information
collection should be sent on or before August 22, 2019 to Nicholas A.
Fraser, OMB Desk Officer, via email to [email protected],
or by fax to 202-395-5167, marked to the attention of Nicholas A.
Fraser.
Marcie Lovett,
Chief, Records and Information Governance Branch, Office of the Chief
Administrative Officer, United States Patent and Trademark Office.
[FR Doc. 2019-15562 Filed 7-22-19; 8:45 am]
BILLING CODE 3510-16-P
